Evogene Ltd (EVGN)

[midastouch017]

Evogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023

https://finance.yahoo.com/news/evogene-schedules-second-quarter-2023-110000976.html

Conference call scheduled for 9:00 AM ET

REHOVOT, Israel, Aug. 1, 2023 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN)(TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development across multiple market segments, announced today that it will release its financial results for the second quarter of 2023, on Thursday, August 17, 2023.

Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time).

To join the conference call, please use the following numbers: [phone] toll-free from the United States or [phone] internationally. You can also find access details for the call at https://evogene.com/investor-relations/presentations-and-webcasts/

A replay of the conference call will be available approximately two hours following the completion of the call. To access the replay, please dial [phone] toll-free from the United States or [phone] internationally. The telephone replay will be accessible for three days, but an archive of the webcast will be available from the webcast link for the following twelve months.